NRx Pharmaceuticals (NASDAQ:NRXP) on Monday reported the minutes of a Type B meeting with the U.S. Food and Drug Administration's (FDA) Division of Psychiatry Products held on Jan. 11 linked to filing ...
"Study May Proceed" letter received from FDA IND preclinical requirements are consistent with studies already in progress to support treatment of Bipolar Depression Potential to initiate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback